Alyssa Fasciano

Alyssa Fasciano is a Senior Scientist in Translational Medicine at Kymera Therapeutics, with previous experience as a Scientist II in the same field. Prior roles include a Scientist I in Immuno-oncology Target Validation at Celsius Therapeutics, where Alyssa led validation projects and developed complex immunological assays. At Tufts University School of Medicine, Alyssa served as a Postdoctoral Scholar, investigating the immunological impact of Yersinia pseudotuberculosis. Alyssa completed a Ph.D. in Immunology at Tufts University, where multidisciplinary research was conducted under Dr. Joan Mecsas, following an undergraduate research background at the University of Connecticut and Connecticut Children's Hospital.